Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
1.650
-0.030 (-1.79%)
At close: Jan 8, 2026, 4:00 PM EST
1.860
+0.210 (12.73%)
After-hours: Jan 8, 2026, 5:03 PM EST
Adagene Market Cap
Adagene has a market cap or net worth of $77.77 million as of January 8, 2026. Its market cap has decreased by -12.61% in one year.
Market Cap
77.77M
Enterprise Value
23.20M
1-Year Change
-12.61%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $77.77M, a decrease of -90.33%. That is a compound annual growth rate of -37.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 79.18M | -11.11% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | 804.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |